protein annotations Search Results


glycosylation annotations on the fnl protein detail page  (Glygen Corporation)
90
Glygen Corporation glycosylation annotations on the fnl protein detail page
Glycosylation Annotations On The Fnl Protein Detail Page, supplied by Glygen Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glycosylation annotations on the fnl protein detail page/product/Glygen Corporation
Average 90 stars, based on 1 article reviews
glycosylation annotations on the fnl protein detail page - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
protein domain annotation  (InterPro Inc)
90
InterPro Inc protein domain annotation
Protein Domain Annotation, supplied by InterPro Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protein domain annotation/product/InterPro Inc
Average 90 stars, based on 1 article reviews
protein domain annotation - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
hypothetical protein pc21g12970  (Biotechnology Information)
90
Biotechnology Information hypothetical protein pc21g12970
Hypothetical Protein Pc21g12970, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hypothetical protein pc21g12970/product/Biotechnology Information
Average 90 stars, based on 1 article reviews
hypothetical protein pc21g12970 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
knowledge-based annotations  (Human Protein Atlas)
90
Human Protein Atlas knowledge-based annotations
Knowledge Based Annotations, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/knowledge-based annotations/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
knowledge-based annotations - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
genes annotated as “protein coding  (Biomark Inc)
90
Biomark Inc genes annotated as “protein coding
Genes Annotated As “Protein Coding, supplied by Biomark Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genes annotated as “protein coding/product/Biomark Inc
Average 90 stars, based on 1 article reviews
genes annotated as “protein coding - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
genome sequences, protein sequences, and annotation files of p. sinensis  (Biotechnology Information)
90
Biotechnology Information genome sequences, protein sequences, and annotation files of p. sinensis
DKK protein analysis of <t> P. sinensis </t> .
Genome Sequences, Protein Sequences, And Annotation Files Of P. Sinensis, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genome sequences, protein sequences, and annotation files of p. sinensis/product/Biotechnology Information
Average 90 stars, based on 1 article reviews
genome sequences, protein sequences, and annotation files of p. sinensis - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
lifeseq annotated gene and expressed sequence-tag databases; proteome bioknowledge library species-specific protein information databases; bioinformatics software  (Incyte corporation)
90
Incyte corporation lifeseq annotated gene and expressed sequence-tag databases; proteome bioknowledge library species-specific protein information databases; bioinformatics software
DKK protein analysis of <t> P. sinensis </t> .
Lifeseq Annotated Gene And Expressed Sequence Tag Databases; Proteome Bioknowledge Library Species Specific Protein Information Databases; Bioinformatics Software, supplied by Incyte corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lifeseq annotated gene and expressed sequence-tag databases; proteome bioknowledge library species-specific protein information databases; bioinformatics software/product/Incyte corporation
Average 90 stars, based on 1 article reviews
lifeseq annotated gene and expressed sequence-tag databases; proteome bioknowledge library species-specific protein information databases; bioinformatics software - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
immunohistochemical protein data  (Human Protein Atlas)
90
Human Protein Atlas immunohistochemical protein data
a. Kaplan-Meier relapse-free survival (RFS) curves for patients with low or high PEAK1 transcript levels across all breast cancer subtypes (n = 1784). b. Kaplan-Meier RFS curves for HER2-positive breast cancer patients with low or high PEAK1 transcript levels (n = 272). c. PEAK1 transcript levels in normal breast stroma and breast cancer stroma across all subtypes (n = 6 and 53, respectively). d. PEAK1 transcript levels in breast cancer stroma of relapse-free patients and those with disease recurrence across all subtypes (n = 42 and 11, respectively). e. Expression correlation and linear regression analyses of PEAK1 and ETS1, KLF4, SNAI2, FN1, FOXC2 and MYC across patients having mixed or good outcomes (top, n = 45) and patients having poor outcomes (bottom, n = 8). f. Representative <t>IHC</t> images for HER2, PEAK1, SNAI2, MYC and FN1 in breast cancer tissue where PEAK1 expression in the stromal compartment is low (top) or high (bottom). g. Stromal IHC score correlation and linear regression analyses of PEAK1 and SNAI2, MYC and FN1 across six breast cancer tissue samples (patient #s 1874, 1939, 2428, 1920, 2392 and 3257). h. Average stromal IHC scores for PEAK1, SNAI2, MYC and FN1 in three HER2-negative patients and three HER2-positive patients. i-j. Kaplan-Meier overall survival (OS) curves for patients with low or high PEAK1 (h) or SNAI2 (i) transcript levels across all breast cancer subtypes (n = 1089). k-l. Kaplan-Meier OS curves for low or high PEAK1 transcript levels in breast cancer patients selected for low (j) or high (k) SNAI2 expression (n = 544). m. Kaplan-Meier RFS curves for low or high PEAK1 transcript levels in HER2-positive breast cancer patient selected for high SNAI2 expression (n = 75). * or ** indicates p-value < 0.05 or 0.01, respectively, as determined by a Student’s T-test.
Immunohistochemical Protein Data, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immunohistochemical protein data/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
immunohistochemical protein data - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
protein annotations  (Biotechnology Information)
90
Biotechnology Information protein annotations
a. Kaplan-Meier relapse-free survival (RFS) curves for patients with low or high PEAK1 transcript levels across all breast cancer subtypes (n = 1784). b. Kaplan-Meier RFS curves for HER2-positive breast cancer patients with low or high PEAK1 transcript levels (n = 272). c. PEAK1 transcript levels in normal breast stroma and breast cancer stroma across all subtypes (n = 6 and 53, respectively). d. PEAK1 transcript levels in breast cancer stroma of relapse-free patients and those with disease recurrence across all subtypes (n = 42 and 11, respectively). e. Expression correlation and linear regression analyses of PEAK1 and ETS1, KLF4, SNAI2, FN1, FOXC2 and MYC across patients having mixed or good outcomes (top, n = 45) and patients having poor outcomes (bottom, n = 8). f. Representative <t>IHC</t> images for HER2, PEAK1, SNAI2, MYC and FN1 in breast cancer tissue where PEAK1 expression in the stromal compartment is low (top) or high (bottom). g. Stromal IHC score correlation and linear regression analyses of PEAK1 and SNAI2, MYC and FN1 across six breast cancer tissue samples (patient #s 1874, 1939, 2428, 1920, 2392 and 3257). h. Average stromal IHC scores for PEAK1, SNAI2, MYC and FN1 in three HER2-negative patients and three HER2-positive patients. i-j. Kaplan-Meier overall survival (OS) curves for patients with low or high PEAK1 (h) or SNAI2 (i) transcript levels across all breast cancer subtypes (n = 1089). k-l. Kaplan-Meier OS curves for low or high PEAK1 transcript levels in breast cancer patients selected for low (j) or high (k) SNAI2 expression (n = 544). m. Kaplan-Meier RFS curves for low or high PEAK1 transcript levels in HER2-positive breast cancer patient selected for high SNAI2 expression (n = 75). * or ** indicates p-value < 0.05 or 0.01, respectively, as determined by a Student’s T-test.
Protein Annotations, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protein annotations/product/Biotechnology Information
Average 90 stars, based on 1 article reviews
protein annotations - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
annotated proteins data base  (Genoscope)
90
Genoscope annotated proteins data base
a. Kaplan-Meier relapse-free survival (RFS) curves for patients with low or high PEAK1 transcript levels across all breast cancer subtypes (n = 1784). b. Kaplan-Meier RFS curves for HER2-positive breast cancer patients with low or high PEAK1 transcript levels (n = 272). c. PEAK1 transcript levels in normal breast stroma and breast cancer stroma across all subtypes (n = 6 and 53, respectively). d. PEAK1 transcript levels in breast cancer stroma of relapse-free patients and those with disease recurrence across all subtypes (n = 42 and 11, respectively). e. Expression correlation and linear regression analyses of PEAK1 and ETS1, KLF4, SNAI2, FN1, FOXC2 and MYC across patients having mixed or good outcomes (top, n = 45) and patients having poor outcomes (bottom, n = 8). f. Representative <t>IHC</t> images for HER2, PEAK1, SNAI2, MYC and FN1 in breast cancer tissue where PEAK1 expression in the stromal compartment is low (top) or high (bottom). g. Stromal IHC score correlation and linear regression analyses of PEAK1 and SNAI2, MYC and FN1 across six breast cancer tissue samples (patient #s 1874, 1939, 2428, 1920, 2392 and 3257). h. Average stromal IHC scores for PEAK1, SNAI2, MYC and FN1 in three HER2-negative patients and three HER2-positive patients. i-j. Kaplan-Meier overall survival (OS) curves for patients with low or high PEAK1 (h) or SNAI2 (i) transcript levels across all breast cancer subtypes (n = 1089). k-l. Kaplan-Meier OS curves for low or high PEAK1 transcript levels in breast cancer patients selected for low (j) or high (k) SNAI2 expression (n = 544). m. Kaplan-Meier RFS curves for low or high PEAK1 transcript levels in HER2-positive breast cancer patient selected for high SNAI2 expression (n = 75). * or ** indicates p-value < 0.05 or 0.01, respectively, as determined by a Student’s T-test.
Annotated Proteins Data Base, supplied by Genoscope, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/annotated proteins data base/product/Genoscope
Average 90 stars, based on 1 article reviews
annotated proteins data base - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
high-confidence annotations  (Human Protein Atlas)
90
Human Protein Atlas high-confidence annotations
a. Kaplan-Meier relapse-free survival (RFS) curves for patients with low or high PEAK1 transcript levels across all breast cancer subtypes (n = 1784). b. Kaplan-Meier RFS curves for HER2-positive breast cancer patients with low or high PEAK1 transcript levels (n = 272). c. PEAK1 transcript levels in normal breast stroma and breast cancer stroma across all subtypes (n = 6 and 53, respectively). d. PEAK1 transcript levels in breast cancer stroma of relapse-free patients and those with disease recurrence across all subtypes (n = 42 and 11, respectively). e. Expression correlation and linear regression analyses of PEAK1 and ETS1, KLF4, SNAI2, FN1, FOXC2 and MYC across patients having mixed or good outcomes (top, n = 45) and patients having poor outcomes (bottom, n = 8). f. Representative <t>IHC</t> images for HER2, PEAK1, SNAI2, MYC and FN1 in breast cancer tissue where PEAK1 expression in the stromal compartment is low (top) or high (bottom). g. Stromal IHC score correlation and linear regression analyses of PEAK1 and SNAI2, MYC and FN1 across six breast cancer tissue samples (patient #s 1874, 1939, 2428, 1920, 2392 and 3257). h. Average stromal IHC scores for PEAK1, SNAI2, MYC and FN1 in three HER2-negative patients and three HER2-positive patients. i-j. Kaplan-Meier overall survival (OS) curves for patients with low or high PEAK1 (h) or SNAI2 (i) transcript levels across all breast cancer subtypes (n = 1089). k-l. Kaplan-Meier OS curves for low or high PEAK1 transcript levels in breast cancer patients selected for low (j) or high (k) SNAI2 expression (n = 544). m. Kaplan-Meier RFS curves for low or high PEAK1 transcript levels in HER2-positive breast cancer patient selected for high SNAI2 expression (n = 75). * or ** indicates p-value < 0.05 or 0.01, respectively, as determined by a Student’s T-test.
High Confidence Annotations, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/high-confidence annotations/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
high-confidence annotations - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
proteins annotated as exclusively cytoplasmic or exclusively nuclear  (Human Protein Atlas)
90
Human Protein Atlas proteins annotated as exclusively cytoplasmic or exclusively nuclear
a. Kaplan-Meier relapse-free survival (RFS) curves for patients with low or high PEAK1 transcript levels across all breast cancer subtypes (n = 1784). b. Kaplan-Meier RFS curves for HER2-positive breast cancer patients with low or high PEAK1 transcript levels (n = 272). c. PEAK1 transcript levels in normal breast stroma and breast cancer stroma across all subtypes (n = 6 and 53, respectively). d. PEAK1 transcript levels in breast cancer stroma of relapse-free patients and those with disease recurrence across all subtypes (n = 42 and 11, respectively). e. Expression correlation and linear regression analyses of PEAK1 and ETS1, KLF4, SNAI2, FN1, FOXC2 and MYC across patients having mixed or good outcomes (top, n = 45) and patients having poor outcomes (bottom, n = 8). f. Representative <t>IHC</t> images for HER2, PEAK1, SNAI2, MYC and FN1 in breast cancer tissue where PEAK1 expression in the stromal compartment is low (top) or high (bottom). g. Stromal IHC score correlation and linear regression analyses of PEAK1 and SNAI2, MYC and FN1 across six breast cancer tissue samples (patient #s 1874, 1939, 2428, 1920, 2392 and 3257). h. Average stromal IHC scores for PEAK1, SNAI2, MYC and FN1 in three HER2-negative patients and three HER2-positive patients. i-j. Kaplan-Meier overall survival (OS) curves for patients with low or high PEAK1 (h) or SNAI2 (i) transcript levels across all breast cancer subtypes (n = 1089). k-l. Kaplan-Meier OS curves for low or high PEAK1 transcript levels in breast cancer patients selected for low (j) or high (k) SNAI2 expression (n = 544). m. Kaplan-Meier RFS curves for low or high PEAK1 transcript levels in HER2-positive breast cancer patient selected for high SNAI2 expression (n = 75). * or ** indicates p-value < 0.05 or 0.01, respectively, as determined by a Student’s T-test.
Proteins Annotated As Exclusively Cytoplasmic Or Exclusively Nuclear, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/proteins annotated as exclusively cytoplasmic or exclusively nuclear/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
proteins annotated as exclusively cytoplasmic or exclusively nuclear - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


DKK protein analysis of P. sinensis .

Journal: Animals : an Open Access Journal from MDPI

Article Title: Whole-Genome Identification and Characterization of the DKK Gene Family and Its Transcription Profiles: An Analysis of the Chinese Soft-Shell Turtle ( Pelodiscus sinensis )

doi: 10.3390/ani14060931

Figure Lengend Snippet: DKK protein analysis of P. sinensis .

Article Snippet: All genome sequences, protein sequences, and annotation files of P. sinensis were obtained from the National Center for Biotechnology Information (NCBI) database in the United States.

Techniques: Molecular Weight

a. Kaplan-Meier relapse-free survival (RFS) curves for patients with low or high PEAK1 transcript levels across all breast cancer subtypes (n = 1784). b. Kaplan-Meier RFS curves for HER2-positive breast cancer patients with low or high PEAK1 transcript levels (n = 272). c. PEAK1 transcript levels in normal breast stroma and breast cancer stroma across all subtypes (n = 6 and 53, respectively). d. PEAK1 transcript levels in breast cancer stroma of relapse-free patients and those with disease recurrence across all subtypes (n = 42 and 11, respectively). e. Expression correlation and linear regression analyses of PEAK1 and ETS1, KLF4, SNAI2, FN1, FOXC2 and MYC across patients having mixed or good outcomes (top, n = 45) and patients having poor outcomes (bottom, n = 8). f. Representative IHC images for HER2, PEAK1, SNAI2, MYC and FN1 in breast cancer tissue where PEAK1 expression in the stromal compartment is low (top) or high (bottom). g. Stromal IHC score correlation and linear regression analyses of PEAK1 and SNAI2, MYC and FN1 across six breast cancer tissue samples (patient #s 1874, 1939, 2428, 1920, 2392 and 3257). h. Average stromal IHC scores for PEAK1, SNAI2, MYC and FN1 in three HER2-negative patients and three HER2-positive patients. i-j. Kaplan-Meier overall survival (OS) curves for patients with low or high PEAK1 (h) or SNAI2 (i) transcript levels across all breast cancer subtypes (n = 1089). k-l. Kaplan-Meier OS curves for low or high PEAK1 transcript levels in breast cancer patients selected for low (j) or high (k) SNAI2 expression (n = 544). m. Kaplan-Meier RFS curves for low or high PEAK1 transcript levels in HER2-positive breast cancer patient selected for high SNAI2 expression (n = 75). * or ** indicates p-value < 0.05 or 0.01, respectively, as determined by a Student’s T-test.

Journal: bioRxiv

Article Title: A SNAI2-PEAK1 stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting a cytokine expression profile that converges on PI3K/Akt signaling

doi: 10.1101/2020.05.15.098772

Figure Lengend Snippet: a. Kaplan-Meier relapse-free survival (RFS) curves for patients with low or high PEAK1 transcript levels across all breast cancer subtypes (n = 1784). b. Kaplan-Meier RFS curves for HER2-positive breast cancer patients with low or high PEAK1 transcript levels (n = 272). c. PEAK1 transcript levels in normal breast stroma and breast cancer stroma across all subtypes (n = 6 and 53, respectively). d. PEAK1 transcript levels in breast cancer stroma of relapse-free patients and those with disease recurrence across all subtypes (n = 42 and 11, respectively). e. Expression correlation and linear regression analyses of PEAK1 and ETS1, KLF4, SNAI2, FN1, FOXC2 and MYC across patients having mixed or good outcomes (top, n = 45) and patients having poor outcomes (bottom, n = 8). f. Representative IHC images for HER2, PEAK1, SNAI2, MYC and FN1 in breast cancer tissue where PEAK1 expression in the stromal compartment is low (top) or high (bottom). g. Stromal IHC score correlation and linear regression analyses of PEAK1 and SNAI2, MYC and FN1 across six breast cancer tissue samples (patient #s 1874, 1939, 2428, 1920, 2392 and 3257). h. Average stromal IHC scores for PEAK1, SNAI2, MYC and FN1 in three HER2-negative patients and three HER2-positive patients. i-j. Kaplan-Meier overall survival (OS) curves for patients with low or high PEAK1 (h) or SNAI2 (i) transcript levels across all breast cancer subtypes (n = 1089). k-l. Kaplan-Meier OS curves for low or high PEAK1 transcript levels in breast cancer patients selected for low (j) or high (k) SNAI2 expression (n = 544). m. Kaplan-Meier RFS curves for low or high PEAK1 transcript levels in HER2-positive breast cancer patient selected for high SNAI2 expression (n = 75). * or ** indicates p-value < 0.05 or 0.01, respectively, as determined by a Student’s T-test.

Article Snippet: Immunohistochemical protein data from patient breast tumors are available in the Human Protein Atlas ( http://www.proteinatlas.org ).

Techniques: Expressing